"Radiotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
| Descriptor ID |
D018714
|
| MeSH Number(s) |
E02.186.775 E02.815.600
|
| Concept/Terms |
Radiotherapy, Adjuvant- Radiotherapy, Adjuvant
- Adjuvant Radiotherapy
- Adjuvant Radiotherapies
- Radiotherapies, Adjuvant
|
Below are MeSH descriptors whose meaning is more general than "Radiotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Radiotherapy, Adjuvant".
This graph shows the total number of publications written about "Radiotherapy, Adjuvant" by people in this website by year, and whether "Radiotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 5 | 5 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 1 | 3 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 3 | 3 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 2 | 4 |
| 2020 | 1 | 4 | 5 |
| 2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiotherapy, Adjuvant" by people in Profiles.
-
Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study. World Neurosurg. 2022 01; 157:e245-e253.
-
Merkel cell carcinoma: treatment and outcomes over a 10-year period at a high-volume academic center. Int J Dermatol. 2022 May; 61(5):558-563.
-
A prospective single-institution study of intraoperative radiotherapy (IORT) for early-stage breast cancer. Breast J. 2021 03; 27(3):231-236.
-
Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 cases. J Neurooncol. 2021 Jan; 151(2):241-247.
-
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecol Oncol. 2021 02; 160(2):625-632.
-
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II. J Urol. 2021 Jan; 205(1):22-29.
-
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. J Urol. 2021 Jan; 205(1):14-21.
-
Radiotherapy in addition to surgical resection may not improve overall survival in WHO grade II spinal ependymomas. Clin Neurol Neurosurg. 2020 02; 189:105632.
-
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis. World Neurosurg. 2020 Jan; 133:e804-e812.
-
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer. J Clin Oncol. 2019 07 20; 37(21):1810-1818.